DK1994152T3 - Peptider der er effektive i behandlingen af tumorer og andre tilstande der kræver fjernelse eller destruktion af celler - Google Patents

Peptider der er effektive i behandlingen af tumorer og andre tilstande der kræver fjernelse eller destruktion af celler

Info

Publication number
DK1994152T3
DK1994152T3 DK07710660.7T DK07710660T DK1994152T3 DK 1994152 T3 DK1994152 T3 DK 1994152T3 DK 07710660 T DK07710660 T DK 07710660T DK 1994152 T3 DK1994152 T3 DK 1994152T3
Authority
DK
Denmark
Prior art keywords
tumors
destruction
treatment
cell removal
conditions requiring
Prior art date
Application number
DK07710660.7T
Other languages
English (en)
Inventor
Paul A Averback
Jack Gemmell
Original Assignee
Nymox Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nymox Corp filed Critical Nymox Corp
Application granted granted Critical
Publication of DK1994152T3 publication Critical patent/DK1994152T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
DK07710660.7T 2006-02-28 2007-02-28 Peptider der er effektive i behandlingen af tumorer og andre tilstande der kræver fjernelse eller destruktion af celler DK1994152T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77693306P 2006-02-28 2006-02-28
PCT/CA2007/000318 WO2007098588A1 (en) 2006-02-28 2007-02-28 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells

Publications (1)

Publication Number Publication Date
DK1994152T3 true DK1994152T3 (da) 2013-03-11

Family

ID=38458614

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07710660.7T DK1994152T3 (da) 2006-02-28 2007-02-28 Peptider der er effektive i behandlingen af tumorer og andre tilstande der kræver fjernelse eller destruktion af celler

Country Status (17)

Country Link
US (2) US8067378B2 (da)
EP (1) EP1994152B1 (da)
JP (1) JP2009528298A (da)
KR (1) KR20080110765A (da)
CN (1) CN101389760A (da)
AU (1) AU2007219669A1 (da)
BR (1) BRPI0708340A2 (da)
CA (1) CA2643100A1 (da)
DK (1) DK1994152T3 (da)
EA (1) EA200801853A1 (da)
ES (1) ES2400920T3 (da)
MX (1) MX2008010942A (da)
PL (1) PL1994152T3 (da)
PT (1) PT1994152E (da)
SI (1) SI1994152T1 (da)
WO (1) WO2007098588A1 (da)
ZA (1) ZA200807394B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1994152T1 (sl) * 2006-02-28 2013-05-31 Nymox Corporation Peptidi uäśinkoviti pri zdravljenju tumorjev in ostalih stanj, ki zahtevajo odstranitev ali uniäśenje celic
US20080027005A1 (en) * 2006-07-31 2008-01-31 Paul Averback Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
JP2017525370A (ja) 2014-08-21 2017-09-07 ザ ジェネラル ホスピタル コーポレイション 腫瘍壊死因子スーパーファミリーおよびｔｎｆ様リガンドムテインならびに腫瘍壊死因子スーパーファミリーおよびｔｎｆ様リガンドムテインを調製および使用する方法
US20160215031A1 (en) * 2015-01-27 2016-07-28 Nymox Pharnaceutical Corporation Method of treating disorders requiring destruction or removal of cells
US20160361380A1 (en) * 2015-06-12 2016-12-15 Nymox Corporation Combination compositions for treating disorders requiring removal or destruction of unwanted cellular proliferations
US11628202B2 (en) 2015-07-24 2023-04-18 Nymox Corporation Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia
US10183058B2 (en) * 2016-06-17 2019-01-22 Nymox Corporation Method of preventing or reducing the progression of prostate cancer
US10172910B2 (en) * 2016-07-28 2019-01-08 Nymox Corporation Method of preventing or reducing the incidence of acute urinary retention
US10532081B2 (en) * 2016-09-07 2020-01-14 Nymox Corporation Method of ameliorating or preventing the worsening or the progression of symptoms of BPH
US10835538B2 (en) 2018-03-28 2020-11-17 Nymox Corporation Method of treating benign prostatic hyperlasia with antibiotics
US20200061150A1 (en) 2018-08-23 2020-02-27 Nymox Corporation Method of inducing selective prostate glandular pharmaco-ablation with sparing of nerves and preservation of sexual function
US20200360466A1 (en) 2019-05-13 2020-11-19 Nymox Corporation Method of improving lower urinary tract symptoms
US11298400B2 (en) 2019-05-13 2022-04-12 Nymox Corporation Method of enhancing the therapeutic efficacy of fexapotide triflutate in treating LUTS
US11278588B2 (en) 2019-05-13 2022-03-22 Nymox Corporation Method of treating lower urinary tract symptoms with fexapotide triflutate
US11231421B2 (en) 2019-07-31 2022-01-25 Nymox Corporation Methods of treating multifocal cancer
US11331374B2 (en) 2019-07-31 2022-05-17 Nymox Corporation Focal treatment of prostate cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4752602A (en) * 1985-09-09 1988-06-21 Board Of Regents, The University Of Texas System Dipeptide alkyl esters and their uses
US6916605B1 (en) * 1990-07-10 2005-07-12 Medical Research Council Methods for producing members of specific binding pairs
KR100392244B1 (ko) 1993-04-20 2003-11-28 더 제너럴 호스피탈 코포레이션 신경사단백질유전자발현및알쯔하이머병의검출
CU22921A1 (es) * 1999-11-16 2004-02-20 Centro Inmunologia Molecular Anticuerpos quimérico, humanizado y el fragmento de tipo fv de cadena sencilla que reconoce el antígeno c2. su uso en el diagnóstico y tratamiento de tumores colorrectales
JP2003534001A (ja) * 2000-05-24 2003-11-18 エフ．ホフマン−ラ ロシュ アーゲー プロｐｓａの特定形態に対する抗体およびそのイムノアッセイにおける使用
EP1541166B1 (en) 2001-05-16 2007-12-19 Nymox Corporation Preventing cell death using segments of neural thread proteins
MXPA04000561A (es) 2001-07-19 2005-02-17 Nymox Corp Peptidos eficaces en el tratamiento de tumores y otras condiciones que requieren la remocion o destruccion de celulas.
US7317077B2 (en) * 2001-11-16 2008-01-08 Nymox Pharmaceutical Corporation Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
SI1994152T1 (sl) * 2006-02-28 2013-05-31 Nymox Corporation Peptidi uäśinkoviti pri zdravljenju tumorjev in ostalih stanj, ki zahtevajo odstranitev ali uniäśenje celic

Also Published As

Publication number Publication date
EP1994152A4 (en) 2009-04-01
PL1994152T3 (pl) 2013-05-31
ZA200807394B (en) 2009-08-26
US8067378B2 (en) 2011-11-29
US8716247B2 (en) 2014-05-06
PT1994152E (pt) 2013-03-13
MX2008010942A (es) 2008-09-03
CN101389760A (zh) 2009-03-18
AU2007219669A1 (en) 2007-09-07
BRPI0708340A2 (pt) 2011-05-24
US20120114679A1 (en) 2012-05-10
SI1994152T1 (sl) 2013-05-31
EP1994152A1 (en) 2008-11-26
CA2643100A1 (en) 2007-09-07
EP1994152B1 (en) 2012-12-12
US20080176805A1 (en) 2008-07-24
EA200801853A1 (ru) 2009-02-27
ES2400920T3 (es) 2013-04-15
JP2009528298A (ja) 2009-08-06
WO2007098588A1 (en) 2007-09-07
KR20080110765A (ko) 2008-12-19

Similar Documents

Publication Publication Date Title
DK1994152T3 (da) Peptider der er effektive i behandlingen af tumorer og andre tilstande der kræver fjernelse eller destruktion af celler
DK2114419T3 (da) Natriummetaarsenit til anvendelse i behandling af smerte og inflammation
DK2342233T3 (da) Anti-CXCR4-antistoffer og anvendelse deraf i behandling af cancer
DK2331109T3 (da) Fremgangsmåder og sammensætninger til behandling af knogledefekter med placentale cellepopulationer
DK2252342T3 (da) Indretninger og fremgangsmåder til behandling af skadet væv
DK1917246T3 (da) Benzoquinazolinderivater og deres anvendelse til behandling af knoglesygdomme
DK2483278T3 (da) Benzoxazepin pi3k-inhibitorforbindelser og deres anvendelse i behandlingen af cancer
DK2146733T3 (da) Treatment of leaky or damaged tight junctions and enhancing extracellular matrix
EP1903009A4 (en) APPARATUS AND METHOD FOR TREATING WATER FROM LESTAGE
DK2470191T3 (da) Fremgangsmåder og præparater til forebyggelse eller behandling af oftalmiske tilstande
DK2089361T3 (da) Inhibitorer af natriumglucose-cotransportør 2 og fremgangsmåder til deres anvendelse
DK2687223T4 (da) Påvisning og behandling af demens
DK2010331T3 (da) Fremgangsmåder til udvælgelse og/eller behandling af partikler til selektiv og/eller optimeret lysering af celler
DK2155188T3 (da) Fremgangsmåder og sammensætninger til behandling af tilbagevendende kræft
DK3327030T3 (da) Vacciner og vaccinebestanddele til hæmning af mikrobielle celler
PL2209888T3 (pl) Ulepszony sposób wytwarzania komórek rpe i kompozycji komórek rpe
DK2078073T3 (da) Nyreafledte celler og fremgangsmåder til anvendelse deraf til vævsreparation og -regenerering
DK2306899T3 (da) Påvisning af hypokinetiske og/eller hyperkinetiske tilstande
EP2060040A4 (en) USE OF PHRASE TOKENS IN TRANSACTIONS
DK2063881T3 (da) Sammensætning og fremgangsmåde til virksom og sikker administration af halopyruvat til behandlingen af cancer
HRP20160764T1 (hr) Pseudovirusi papilomavirusa za otkrivanje i liječenje tumora
DK2235002T3 (da) 4-pyridinonforbindelser og anvendelse heraf til behandling af cancer
DK1771201T3 (da) Sammensætninger og fremgangsmåder til behandling eller forebyggelse af oxalat-relateret sygdom
DK2102354T3 (da) Apparater og fremgangsmåder til osmotisk shockering af celler
DK2043671T3 (da) Peptid og sammensætning deraf til anvendelse ved behandling af slagtilfælde med feber